At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 24 enrolled
Drug / intervention
Mulberry Leaf Extract +1 moredrug
Likely dose
Mulberry Leaf Extract 1000 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Mulberry Leaf Extract on Glycemic Durability in Non-insulin Dependent Diabetes Mellitus: a Double-blind, Randomized, Placebo-controlled Pilot Study (Mul-DM)
In Brief
A Phase 3 clinical trial evaluating Mulberry Leaf Extract and Placebo for Type 2 Diabetes. Completed, enrolled 24 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate whether mulberry leaf extract will help control blood sugar in patients with type 2 diabetes. We also want to look at the safety of mulberry leaf extract in these patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2008
First PostedNov 2008
Primary CompletionMay 2010
TodayJul 2026
First PostedNov 21, 2008
Enrollment StartApr 1, 2008
Primary CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 17.6 years ago
Interventions
Mulberry Leaf Extractdrug
Mulberry Leaf Extract 1000 mg by mouth three times daily for 3 months
Placebodrug
Placebo 500 mg #2 capsules by mouth three times daily